Integrating tumor microenvironment biology with clinical impact: Evolving understanding of therapeutic approaches for MF-CTCL - CME - Guideline Central

CME

Title
Integrating tumor microenvironment biology with clinical impact: Evolving understanding of therapeutic approaches for MF-CTCL
Link
Description
Join Dr. Larisa J. Geskin and leading experts for this free, on-demand, CME-accredited webcast examining the role of the tumor microenvironment (TME) in mycosis fungoides–type cutaneous T-cell lymphoma (MF-CTCL). Explore how tumor microenvironment biology influences disease progression and therapeutic response, and how these insights can inform precision-informed treatment selection.
Target Audience
This activity is designed to meet the educational needs of dermapathologists, dermatologists, medical oncologists, and oncodermatologists.
Learning Objectives
  • Increase knowledge and confidence in interpreting MF-CTCL tumor microenvironment biology, recognizing its influence on disease progression and therapy response, and applying this understanding to guide evidence-based clinical decision-making
  • Increase knowledge and confidence in evaluating the cytotoxic and immunomodulatory mechanisms of skin-directed therapies, understanding how these agents modulate the TME to reduce malignant cell burden, enhance antitumor immunity, and guide evidence-based, durable management of MF-CTCL
Estimated Duration
60 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Pathology, Dermatology, Allergy and Immunology
Keywords
lymphoma
Disclosures and Disclaimers
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
Accredited Providers
  • Postgraduate Institute for Medicine
Commercial Support
  • Helsinn Therapeutics (U.S.), Inc
Activity Expiration Date
February 14, 2027
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit1 CreditsACCME- Accreditation Council for Continuing Medical Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.